Also, chaperones (heat shock proteins: Hsp60, Hsp70, Hsp90) became a subject of interest as potential drug targets and DMT strategies to treat AD by blocking the aggregation process of misfolded proteins, like amyloidogenic proteins (i.e., Aβ and tau), and promoting their degradation [113]. The gene discussed is MAPT; the disease is Alzheimer disease.